Peer review has long been considered the gold standard guarantor of good science and medicine. It is also a rubric upon which legal standards of scientific admissibility are based. When the process fails – which is becoming increasingly common – medical practitioners and scientists alike are led astray, as is the law. But while the scientific establishment is becoming aware of the concerns, such awareness is glaringly absent in the law.
Policy & Ethics
It should come as no surprise to anyone trying to get or fill a prescription for a controlled substance that our drug laws are nuts. But you probably don't fully appreciate how nutty they really are. This article just scratches the surface of the nut. But that's still plenty.
“Every hour, across the world, around 742,000 freshly hatched male chicks are born. A few hours later…” they are killed. The males are obviously of no value to the egg-laying sector of the egg economy; and of no value to the meat-producing sector, where their slow weight gain makes them an “inefficient” source of meat. Could there possibly be lessons in the global annual slaughter of 6.5 billion male chicks?
In February, 2021, the CDC published its mask mandate in the federal register requiring a person to “wear a mask while boarding, disembarking or traveling on any conveyance into or within the United States.” Exemptions were provided for specific medical conditions. Several plaintiffs suffering anxiety disturbances from masking (which was not exempted) sued the CDC in Florida district court for exceeding its statutory authority (and for other issues). The court ruled in favor of the plaintiffs and is on appeal. The case directly addresses the powers of the CDC to act during public health emergencies in interstate transport and commerce.
Last year's omnibus appropriation bill passed by Congress made a good start with cybersecurity standards for internet-connected medical devices. But it's only one tiny piece of a large and complex puzzle.
A record of bias and incompetence disqualifies the The Centers for Disease Control (CDC) from further roles in creating public policy for treating patients in pain.
Lost in the debate over how Medicare will negotiate drug prices, there's a concern by federal agencies about a metric used in determining a drug’s value. It's known as the Quality-Adjusted Life Year. There's bipartisan agreement in not using the term QALY, and “not even Medicare officials have signaled they want to use that approach.” What exactly are they talking about?
The stakes are literally life and death. More than 100,000 patients are on the national transplant list, awaiting organ transplants, with thousands needlessly dying before receiving them. For now, a single nonprofit, The United Network for Organ Sharing (UNOS), is the sole organization responsible for matching organ recipients with donors. Last year the 42,888 organ transplants performed were just not enough.
"... [I]nfluenza A, SARS-CoV-2, endemic coronaviruses, RSV, and many other 'common cold' viruses ... have not to date been effectively controlled by licensed or experimental vaccines." So wrote Dr. Tony Fauci, former head of the National Institute of Allergy and Infectious Diseases. What can policymakers learn from this controversial analysis? California is poised to ban five commonly used chemicals under the guise of protecting children. There's no science to justify the legislation.
As humans march toward creating more sophisticated robotics, computers, and AI technology, the question has always lurked: Are these techno-devices human? Will they ever be?
On January 11, the CPSC issued a statement of concern about emissions from gas stoves while stating that it had no plans to ban them. Here are the comments I have submitted to the Commission during its public comment period. It’s time for the larger issue of indoor air pollution to get its due.
The FDA is responsible for the approval of medications in the U.S. Many similar agencies are doing the same work in other countries. But unlike the U.S. – where cost is not a consideration – several countries including the UK, Canada, and Australia, apply a Health Technology Assessment to consider a new medication’s clinical and economic cost and benefits. A recent study shows they disagree with the FDA’s decision about 20% of the time.